BioCentury
ARTICLE | Company News

Inverness, Standard Diagnostics deal

January 18, 2010 8:00 AM UTC

Inverness began a tender offer to acquire up to 75.8% of Standard Diagnostics at KRW40,000 per share, or about KRW242.5 billion ($218.3 million). The price is a 5.7% premium to Standard Diagnostics' c...